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CHAPTER ONE 
1.1. INTRODUCTION 
1.1.1. The Colorectal Cancer 
Colorectal cancer, also called colon cancer or large bowel cancer includes 
cancerous growths in the colon, rectum and appendix. With 655,000 deaths 
worldwide per year, it is the fourth most common form of cancer in the United 
States and the third leading cause of cancer-related death in the Western world 
(WHO, 2006). Colorectal cancer is the third commonest cause of cancer deaths in 
Malaysia.  Data from the Malaysian Ministry of Health confirms an increase in 
colorectal cancer admission rates from 8.1% in 1987 to 11.9% in 1995 (MOH, 
1995). Colorectal cancers arise from adenomatous polyps in the colon. These 
mushroom-shaped growths are usually benign, but some develop into cancer over 
time. Localized colon cancer is usually diagnosed through colonoscopy. 
1.1.2. Aberrant Crypt Foci (ACF) 
Aberrant crypt foci (ACF) are clusters of abnormal glands that look like tubes. 
They lined the colon of the rectum. Aberrant crypt foci form is among the observed 
earliest changes in the colon that may lead to cancer, as they are formed before 
colorectal polyps. ACF are, as opposed to normal epithelial cells, apoptosis 
resistant (Takayama et al., 2005).  They are putative precursors of colon cancer 
(Adler, 2005). It was first described in 1987 by Dr. Ranjana Bird at the University 
of Toronto. She observed that in experimental animals given a synthetic colon 
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carcinogen, certain changes occur in the topography of the colon in a few weeks, 
long before any tumor develops. When the colon was removed, cut open 
lengthwise, stained with a blue dye, and viewed under the microscope, small 
clusters or "foci: of darkly stained crypts with thickened walls could be seen. 
Importantly, the ACF has also been observed in resected human colons, and some 
contain mutations that are found commonly in human colon tumors (Roderick, 
1998). Twenty years later, more than 900 articles deal with ACF on Pub Med data 
base. Many indirect evidences support the hypothesis that ACF are precancerous 
lesions (Corpet, 2010). Corpet (2010) reported the correlation between tumor 
incidence and number of large ACF (r = 0.76, p<0.001, N = 36), which was viewed 
as a major piece of evidence to support the above mentioned hypothesis. 
The crypts in ACF are easy to score on whole mount colon. ACF are observed to 
be two to three times larger than normal crypts, microscopically elevated, have a 
slit-like opening, have a thick epithelial lining that stains darker than normal 
crypts, with a large per-cryptal zone (Corpet and Tache, 2002). When looking for 
aberrant crypt foci with microscopy, methylene blue is used as a staining agent 
(Takayama et al., 2005). The resulting figure (Figure 1.1.) is fairly easy to detect 
under the microscope at low magnification (4x) (Corpet and Tache, 2002). 
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Figure 1.1. Aberrant crypt foci lesions (Corpet and Tache, 2002) 
It has been elucidated that ACF  were induced by all colon carcinogens in a dose- 
and species-dependent manner (Bruce and Corpet, 1996). ACF number and growth 
were modified by the modulators of colon carcinogenesis, and they predicted the 
tumor outcome in several rodent studies; it was also found to  correlate with colon 
cancer risk, and adenoma size and number in humans; in fact the morphological 
and genotypic features of ACF in human colons were similar to those in animal 
colons (Bruce and Corpet, 1996). Many alterations in ACF were observed to be 
similar to that in tumors; with some ACF showing dysplasia, and carcinoma in 
rodents and humans' ACF (Bruce and Corpet, 1996). 
Chemically induced ACF in rodents have been used extensively to test chemicals 
and diets that might prevent colorectal cancer, in fact this was reported in more 
than 400 scientific articles (Corpet and Tache, 2002). The "chemoprevention 
database" shows the results of all published scientific studies of chemopreventive 
agents, in people and in animals (Corpet, 2002). 
The use of the ACF system to study modulators of carcinogenesis has been 
accelerated for the last 10 years; this was owed to its advantage of being simple 
and economical tool for preliminary screening of potential chemopreventive 
agents, while allowing a quantitative assessment of the mechanisms of colon 
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carcinogenesis. Though, the role of ACF as preneoplastic lesions was however 
recently challenged, viewing Mucin Depleted Foci (MDF) as a possible candidate 
for better endpoints (or MDF, BCAC, flat ACF, ACF min). Still some researchers 
like Corpet and Tache (2002) argue that ACF are not to be left, because they afford 
a relatively quick and simple way to screen for compounds in the diet that might 
either cause or inhibit colon cancer (Corpet and Tache, 2002). 
1.1.3. Colon Cancer Chemopreventive Effect of Phyllanthus niruri 
Phyllanthus niruri belong to the plant family of Euphorbiaceae. It is 
herbaceous plant that inhabits the tropical and subtropical regions. It has been 
reported to be popularly used in traditional medicine either as whole plant, fresh 
leaves or as fruits in the treatment of various diseases, particularly hepatitis and 
other viral infection (Wang, 2000). This plant is reported to have medicinal 
importance for numerous ailments like dysentery, influenza, vaginitis, tumors, 
diabetes, diuretics, jaundice, kidney stone, dyspepsia, antihepatotoxic, 
antihepatitis-B, antihyperglycemic and also as antiviral and antibacterial (Abdulla 
et al., 2010, Chopra et al., 1986). Extract of this plant contains several bioactive 
molecules such as lignans, phyllanthin, hypophyllanthin, flavonoids, glycosides 
and tannins. P. niruri was reported to possess anticarcinogenic (Rajeshkumar et al., 
2002) and antioxidant activities (Abdulla et al., 2010). 
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1.1.4. Antioxidant Activity of Plant Extracts 
Antioxidant activity is popularly used to indicate the ability of an 
antioxidant to scavenge some radicals. Free radical colorimetry relies on the 
reaction of an antioxidant with the stable free radical 2, 2-diphenyl-l-
picrylhydrazyl (DPPH) dissolved in methanol (Buijnsters, 2001). DPPH is a 
relatively stable paramagnetic free radical that accepts electrons or H
+
 radicals to 
become a stable diamagnetic molecule (Brand-Williams, 1995). The reduction of 
DPPH by an antioxidant results in the formation of a purple-blue colored solution 
which gives the measure of the activity by spectrophotometer at 541 nm 
(Buijnsters, 2001).On the other hand, Ferric-reducing antioxidant power (FRAP) 
assay is a well known method for measuring the ferric reducing ability (antioxidant 
power) of plasma. Reduction of ferric to ferrous ion causes a development of blue 
color complex which gives maximum absorption at 593nm. This color 
development indicates that a reductant (antioxidant) is present in the sample 
(Benzie and Strain, 1996). 
Several studies reported that the antioxidant activity of plants extract has a 
beneficial effect of chemoprotection against AOM-induced  cell oxidative stress in 
several human diseases and experimental models of colon cancer (Abdulla et al., 
2010). Plant such as Phyllanthus niruri (Abdulla et al., 2010), P. amarus 
(Rajeshkumar et al., 2002), Vaccinium macrocarpon Ait (Sunkara et al., 2008), 
Aloe arborescens Miller var. (Shimpo et al., 2001), were reported to prevent 
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AOM-induced ACF in experimental model animals due to their free radical 
scavenging property.  
Therefore, this study aimed to evaluation of chemoprotective effects of 
Phyllanthus niruri against AOM-induced foci of aberrant crypts in rats 
1.2. Objectives of the Study 
1.2.1. General Objective 
The main objective of this study is to evaluate chemoprotective effects of 
Phyllanthus niruri against AOM-induced foci of aberrant crypts in rats using rats 
as experimental model animal. The understanding of these effects would pave a 
way to an alternative therapy to this disease. 
1.2.2. Specific Objectives 
1. To determine the acute toxicity of P. niruri whole plant ethanolic extract in 
vivo. 
2. To evaluate the chemoprotective effect of P. niruri against AOM-induced 
foci of aberrant crypts in rats grossly. 
3. To evaluate the antioxidant properties of P. niruri ethanolic extract in vitro. 
 
 
 
 
